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Successive administrations of allylisopropylacetamide, a potent porphyrinogenic drug,
increase liver weight, microsomal protein and phospholipid contents. There is an increase
in the rate of microsomal protein synthesis in vivo and in vitro. The drug decreases micro-
somal ribonuclease activity and increases NADPH-cytochrome c reductase activity.
Phenobarbital, which has been reported to exhibit all these changes mentioned, is a weaker
inducer of 8-aminolaevulinate synthetase and increases the rate of haem synthesis only
after a considerable time-lag in fed female rats, when compared with the effects
observed with allylisopropylacetamide. Again, phenobarbital does not share the property
of allylisopropylacetamide in causing an initial decrease in cytochrome P-450 content.
Haematin does not counteract most of the biochemical effects caused by allylisopropyl-
acetamide, although it is quite effective in the case of phenobarbital. Haematin does not
inhibit the uptake of [2-14C]allylisopropylacetamide by any of the liver subcellular
fractions.
Several foreign chemicals are metabolized by the
mixed-function oxidase system of liver microsomal
material (Conney, 1967; Kuntzman, 1969). It has
been suggested that the drugs induce 8-amino-
laevulinate synthetase, the first and rate-limiting en-
zyme of the haem biosynthetic pathway, thereby
causing increased haem and cytochrome P450 syn-
thesis, which results in enhanced activity ofthe mixed-
function oxidase system (Granick, 1966; Baron &
Tephly, 1969a; Marver, 1969).
Phenobarbital and allylisopropylacetamide cause
increased amounts of 8-aminolaevulinate synthetase
(Baron & Tephly, 1969a; Marver et al., 1966b). Both
compounds increase the rate of haem synthesis
(Marver, 1969). Phenobarbital increases cytochrome
P450 content and causes striking anabolic effects,
such as proliferation of the endoplasmic reticulum
(Orrenius et al., 1965), increased synthesis of protein
(Kato et al., 1965) and lipid (Holtzman & Gillette,
1968), increasedRNA content (Jachau & Fouts, 1966)
and stabilization ofpolyribosomes(Cohen&Ruddon,
1971). Although detailed studies are not available,
administration of allylisopropylacetamide causes an
increase in liver weight, total protein and lipid con-
tents (Marver et al., 1966b; Lottsfeld & Labbe, 1965).
Allylisopropylacetamide also causes proliferation of
the smooth endoplasmic reticulum (Moses et al.,
1970; Biempica etal., 1967; Posalaki & Barka, 1968).
It is not clear whether an increased rate of haem
synthesis owing to allylisopropylacetamide or pheno-
barbital administration has any role in the stimulation
of the anabolic effects of these drugs. Raisfeld et al.
(1970), on the one hand, reported that the pheno-
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barbital-induced increase in cytochrome P450 con-
tent could be blocked by aminotriazole, an inhibitor
of haem synthesis, without significantly interfering
with the processes leading to proliferation of the
endoplasmic reticulum. On the other hand, Marver
(1969) and Marver et al. (1968) reported that extern-
ally administered haematin, the 'co-repressor' for
8-aminolaevulinate synthetase, counteracts the in-
creased cytochrome P-450, protein and lipid contents
caused by phenobarbital. In addition, the induction
of 8-aminolaevulinate synthetase and proliferation
of the endoplasmic reticulum owing to allylisopropyl-
acetamide administration could be related events,
since puromycin and actinomycin D block both the
processes (Biempica et al., 1967).
In the present study the biochemical effects of
allylisopropylacetamide and phenobarbital in rat
liver have been compared and we have examined their
effects on haem synthesis to see ifthey have acommon
basis, causing the other biochemical effects.
Experimental
Materials
Allylisopropylacetamide and [2-14C]allylisopropyl-
acetamide (4.2,Ci/mg) were generously provided by
Hoffmann-La Roche Ltd., Basle, Switzerland. Yeast
RNA, GTP, phosphoenolpyruvate, pyruvate kinase,
fl-mercaptoethanol, NADPH, cytochrome c, glucose
6-phosphate and glucose 6-phosphate dehydrogenase
were all purchased from Sigma Chemical Co., St.
Louis, Mo., U.S.A. Aminopyrine was obtained from
Koch-Light Laboratories, Colnbrook, Bucks., U.K.
M. R. SATYANARAYANA RAO AND G. PADMANABAN
Haemin was prepared from sheep blood by the
method of Labbe & Nishida (1957). All other
chemicals used were of analytical-reagent grade.
[U-14C]Leucine and '4C-labelled Chlorella hydro-
lysate were purchased from Bhabha Atomic Research
Centre, Bombay, India.
Methods
Treatment ofanimals. Female rats (100-1lOg body
wt.) of the local Institute strain were used in all the
experiments. The animals were fed ad libitum on
stock diet obtained from Hindustan Lever Ltd.,
Bombay, India. Allylisopropylacetamide was dis-
solved in 0.1 5M-NaCl and was given subcutaneously
at a dose of 400mg/kg. Sodium phenobarbital was
given intraperitoneally at a concentration of 80mg/
kg. Haemin was dissolved in 0.01 M-KOH and made
up to volume with 0.05M-potassium phosphate
buffer, pH7.5. It was given intraperitoneally at a
dose of 2mg/1OOg. The protocol of each experiment
is given in the respective tables. In experiments in-
volving different periods of drug treatment, the
schedules of injections were started on different days
so that all the animals were ready to be killed on the
same day and time. This was done to avoid the
variations that could arise as a result of the
biochemical analyses being done on different
days.
Treatment of the livers. The animals were killed by
decapitation and the livers were removed and fresh
weights recorded. They were then homogenized with
5vol. of 0.25M-sucrose. The homogenate was centri-
fuged at 15000g for 15min. A known volume of the
post-mitochondrial supernatant was taken and centri-
fuged at 105000g for 1 h in a Beckman L3-50 ultra-
centrifuge. The microsomal pellets obtained were
rinsed once and suspended in 0.25M-sucrose to con-
tain microsomal fractions (microsomes) from 1 g of
liver in 1 ml. All the operations were carried out at
0-4°C. Portions of the microsomal suspensions were
used for determination of protein, RNA and phos-
pholipid contents.
Determination ofcytochrome P-450. For this deter-
mination, the livers were homogenized with 1.15%
KCl and microsomes were isolated as described
above. The pelleted microsomes were rinsed with
1.15% KCI and suspended in 0.05 M-potassium phos-
phate buffer, pH 7.5. Cytochrome P-450 content was
determined by the method of Omura & Sato (1964),
from the CO-difference spectrum of dithionite-re-
duced preparations by using an extinction coefficient
of 91 mm-r Icm-l between 450nm and 490nm.
Analytical methods. Protein was determined by the
method of Lowry et al. (1951) with bovine serum
albumin as the standard. RNA content was deter-
mined by the method of Munro & Fleck (1966). Phos-
pholipid content was determined by the method of
Folch et al. (1957). The liver 8-aminolaevulinate and
porphobilinogen contents were determined by the
method of Satyanarayana Rao et al. (1971).
Enzyme assays. 8-Aminolaevulinate synthetase was
assayed in the liver homogenates by the method of
Marver et al. (1966a).
Ribonuclease activity of the microsomes isolated
from the livers homogenized in 0.25M-sucrose was
determined by the method of Louis-Ferdinand &
Fuller (1970). The incubation mixture contained
0.2ml of 0.2M-Tris-HCI buffer, pH7.6, 1.Omg of
highly polymerized yeast RNA and 6-8mg of micro-
somal protein in a final volume of 1 ml. RNA was
added at the end and the incubation was carried out
in air for 30min at 37°C. After the incubation, 1 ml
of 1 M-HCI in aq. 75% (v/v) ethanol was added and
the mixture was kept in ice for 30min. After centri-
fugation the E260 of the suitably diluted supernatant
was measured. Appropriate controls were employed
for the endogenous contribution of acid-soluble
nucleotides.
NADPH-cytochrome c reductase activity was
determined by the method of Masters et al. (1967), in
which the rate of reduction of cytochrome c was
followed at 550nm by using a Cary 14 spectrophoto-
meter.
Drug-metabolizing enzymes. Aniline hydroxylase
was measured by the method of Imai et al. (1966).
For the assay, the microsomes isolated from livers
homogenized in 1.15 % KCl were used. The reaction
mixture contained 8mM-aniline, 0.32mM-NADP,
3mM-glucose 6-phosphate, 2.5mM-MgCl2, 1.3 units
of glucose 6-phosphate dehydrogenase, lOOmM-Tris-
acetate buffer, pH8.0, and 3-4mg of microsomal
protein in a total volume of 1 ml. The reaction was
carried out for 20min at 37°C aerobically and
stopped by the addition of 0.5ml of 20% (w/v) tri-
chloroacetic acid. The p-aminophenol formed was
measured in I ml of the supernatant by adding 0.5 ml
of 10% (w/v) Na2CO3 and 1 ml of 2% (w/v) phenol
in 0.2M-NaOH and measuring the E630 after 30min.
For measuring the aminopyrine demethylase
activity, the same reaction mixture was used except
that potassium phosphate buffer, pH7.5, was used
instead of Tris-acetate buffer and the total volume
was 3m1, which included 2mM-aminopyrine instead
of aniline and 15mM-semicarbazide. The incubation
was for 15min at 37°C and the reaction was stopped
by the addition of 1 ml of 20% (w/v) trichloroacetic
acid. The formaldehyde formed was determined by
the method of Nash (1953).
Determination of the rate of microsomal protein
synthesis in vivo. The various groups of animals were
injected intraperitoneally with 5,uCi of 14C-labelled
Chlorella protein hydrolysate. After 45 min they were
killed by decapitation and the livers were removed.
The microsomes were isolated from the 0.25 M-
sucrose homogenate as described above, suspended
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in 0.25 M-sucrose and precipitated with trichloroacetic
acid (5 %, w/v, final concentration). The precipitate
was washed once with hot trichloroacetic acid (90°C)
for 20min, twice with cold trichloroacetic acid, once
with ethanol-diethyl ether (2:1, v/v) and finally with
ether. The dry residue was dissolved in 1 ml of formic
acid. A 0.5 ml portion was planchetted on to What-
man no. 3 filter-paper circles for measurement of
radioactivity. Protein was determined in suitably
diluted samples as described above after neutraliza-
tion.
Determination of the rate of protein synthesis in
vitro. The method of Munro et al. (1964) was em-
ployed. The incubation mixture contained 0.1 ml of
the microsomal suspension, 0.2ml of the soluble
factors (pH 5.0 fraction and supernatant factors) and
0.2ml of a mixture containing the following: 19
amino acids except leucine, 0.1l,mol each; ATP,
5,tmol; phosphoenolpyruvate, 2.5,umol; MgCl2,
2.5 ,umol; ,B-mercaptoethanol, 0.2, mol; GTP, 1 ,tmol;
pyruvatekinase, 25,ug; and [U-14C]leucine, 1 uCi. The
reaction was started by the addition of microsomes
and the incubation was carried out for various time-
periods. The reaction was terminated by 5% tri-
chloroacetic acid containing 0.2% (w/v) unlabelled
leucine. The radioactive precipitate was processed
as described above and radioactivity was determined.
RNA was also determined in 0.1 ml of the micro-
somal suspension as described above and the results
are expressed as c.p.m./mg of RNA.
Effect ofallylisopropylacetamide andphenobarbital
on the rate oJ haem synthesis. [2-14C]Glycine was in-jected intraperitoneally into rats 8h after they had
received the last injection of allylisopropylacetamide
or phenobarbital. The animals were killed 1 h after
the tracer (lO,uCi/animal) administration. Haemin
was isolated from the homogenates after the addition
of 1 ml of carrier blood and then recrystallized as
described by Labbe & Nishida (1957). The recrystal-
lized haemin was solubilized in ethyl acetate-acetic
acid (3:1, v/v) and then washed with water and 3M-
HCI to remove porphyrin contamination. One portion
of the ethyl acetate layer was transferred to counting
vials and dried in vacuo for radioactivity measure-
ments. Another portion was evaporated to dryness
under a stream of N2 and the haem content deter-
mined as its pyridine haemochromogen.
Effect ofhaematin on the uptake of [2-14C]allyliso-
propylacetamide by liver subcellular fractions. Haem-
atin was given intraperitoneally at a concentration
of 2mg/1OOg. After 30min allylisopropylacetamide
was injected subcutaneously at a dose of 150 or
400mg/kg, which included 4.2,uCi of [2-14C]allyliso-
propylacetamide. The animals were killed 2h and 4h
after the drug administration when the livers were
removed, homogenized and the subcellular fractions
isolated as described by Beattie & Stuchell (1970).
The homogenate, mitochondria, microsomes and the
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post-microsomal supernatant were then extracted
three times with ethyl acetate-acetic acid (3:1, v/v)
by using 5 volumes each time. The precipitate was
centrifuged and the supernatant was evaporated to
dryness in a desiccator. The final residue was again
dissolved in a known volume of ethyl acetate-
acetic acid and portions were planchetted on to
filter-paper discs for radioactivity measurements.
Ethyl acetate-acetic acid treatment extracted at
least 95% of the radioactivity from all of the liver
fractions.
Radioactivity measurements. These were made in
a Beckman LS-100 liquid-scintillation counter. The
filter-paper discs were counted in vials containing
lOml of 0.5% 2,5-diphenyloxazole in toluene. The
vials containing radioactive haem were also counted
by using the same scintillation fluid, which became
coloured owing to the solubilization ofhaem. Quench
correction was applied by using the channels-ratio
method.
Results
The results presented in Tables 1-3 clearly establish
that successive allylisopropylacetamide administra-
tions stimulate the anabolic processes in the liver.
There is a significant increase in liver weight, micro-
somal protein, RNA and phospholipid contents. The
rate of protein synthesis in vivo shows an increase
(Table 3). The increased rate of protein synthesis
owing to allylisopropylacetamide administration is
also evident in amino acid-incorporation studies with
isolated microsomes (Fig. 1). None of these effects
of allylisopropylacetamide are counteracted by ex-
ternally administered haematin, which by itself ex-
hibits a small but consistent anabolic effect in every
one of the parameters investigated.
With phenobarbital administration, although the
isolated nuclei (Gelboin et al., 1967) and chromatin
(Piper & Bousquet, 1968) have a greater capacity to
synthesize RNA, the enhanced RNA content is not
due to increased rate of synthesis, but may be due
to increased processing or transport of ribosomal
precursor RNA (Cohen & Ruddon, 1970). Also the
microsomal ribonuclease activity is strikingly in-
hibited by successive administrations of phenobarbit-
al (Mycek, 1971). The results in Table 4 show that
successive administrations ofallylisopropylacetamide
also cause a striking decrease in microsomal ribo-
nuclease activity. Haematin by itself depresses ribo-
nuclease activity in vivo and it has been reported to
inhibit erythrocyte ribonuclease activity (Burka,
1970).
Allylisopropylacetamide and phenobarbital cause
an increase in 8-aminolaevulinate synthetase activity
(Baron & Tephly, 1969a; Marver et al., 1966b) and
in the rate of haem synthesis (Marver, 1969). A
detailed study (Table 5) indicates that a single
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Table 3. Rate ofprotein synthesis by the liver micro-
somes in allylisopropylacetamide-treated rats in vivo
The rats were given daily subcutaneous injections of
allylisopropylacetamide (400mg/kg) at 24h intervals.
At 12h after the last injection '4C-labelled Chlorella
hydrosylate (5,uCi/animal) was injected intraperi-
toneally. After 45min the rats were killed and in-
corporations of radioactivity into homogenate and
microsomal protein were measured. The results re-
present the mean±s.D. obtained from three experi-
ments. *P<0.01 with respect to control. The differ-
ence between the control and allylisopropylacetamide-
treated (first day) value is not statistically significant.
Treatment
Control
Allylisopropylacetamide
(first day)
Allylisopropylacetamide
(second day)
Radioactivity in
microsomes
(c.p.m./mg of protein)
256.0± 63.20
349.1 ± 62.84
410.6± 10.10*
injection of allylisopropylacetamide to fed female rats
causes a striking increase in the rate of haem syn-
thesis. The significant increase in total [2-14C]glycine
uptake by the allylisopropylacetamide-injected liver
as compared with the controls or the phenobarbital-
treated ones is interesting. This could be related to
the striking induction of 8-aminolaevulinate syn-
thetase and consequently a necessity to enhance
glycine concentration to saturate the enzyme, since
the enzyme is reported to have a Km value as high as
1 x 1O-2M with respect to glycine (Scholnick et al.,
1970). Phenobarbital does not significantly change
the rate of total haem synthesis in fed female rats
under these conditions. However, a significant in-
crease is seen after the second and third injections
(only the values for the first and third injections are
reported in Table 5).
The results in Table 6 clearly indicate that pheno-
barbital does not significantly induce 8-amino-
laevulinate synthetase 8h after the first injection. A
significant increase in enzyme activity is, however,
seen after the second injection. Haematin counteracts
600 (G
2z
A, 400
200
0 5 10 15 0 5 lo Is
Time (min) Time (min)
Fig. 1. Effect of allylisopropylacetamide and haematin on amino acid incorporation by isolated microsomes
in vitro
The experimental details are given in the text. The results given are those obtained in a typical experiment.
(a) Second day; (b) fourth day. A, Allylisopropylacetamide-treated rats; o, control rats; A, allylisopropyl-
acetamide+haematin-treated rats; e, haematin-treated rats.
Table 4. Effect of dallylisopropylacetamide, phenobarbital and haematin on microsomal ribonuclease activity
The experimental protocol is the same as described in Table 1 and the text. The control value is 0.960±0.100 jtg
ofRNA hydrolysed/30min per mg of protein and represents the means ± S.D. obtained from six experiments. The
other results represent the individual values obtained in each of two experiments.
Microsomal ribonuclease activity
Treatment (jig ofRNA hydrolysed/30min per mg of protein)
Number of days of treatment ...
Allylisopropylacetamide
Haematin
Allylisopropylacetamide+haematin
Phenobarbital
Vol. 134
1
0.672, 0.631
0.856, 0.843
0.586, 0.572
0.601,0.601
2
0.228, 0.290
0.565, 0.501
0.285, 0.234
0.354, 0.383
3
0.265, 0.243
0.538, 0.561
0.305, 0.327
0.250, 0.210
5
0.105, 0.100
0.456, 0.467
0.106, 0.167
0.116,0.128
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Table 5. Effect ofallylisopropylacetamide andphenobarbital on the rate ofhaem synthesis
Rats were given one or three injections of allylisopropylacetamide or phenobarbital at a dose of 400mg/kg and
80mg/kg respectively at 24h intervals. At 8h after the last injection [2-14C]glycine (10tCi/animal) was
injected intraperitoneally into each animal. The animals were killed after 1h and the liver homogenates
processed for haemin isolation after the addition of carrier blood as described in the text. The results represent
the averages of two experiments.
Radioactivity
Treatment
Control
Allylisopropylacetamide
Allylisopropylacetamide
Phenobarbital
Phenobarbital
No. of 10- x Total uptake
injections (c.p.m./g of liver)
1.72
1 5.90
3 4.61
1 1.74
3 1.79
In haemin
(c.p.m./tmol of haemin)
196
931
735
202
345
Table 6. Effect of haem on the porphyrinogenic effects of allylisopropylacetamide and phenobarbital
Rats were given one or two injections of allylisopropylacetamide, phenobarbital and haematin at 24h intervals.
The animals were killed 8h after the last injection. The a-aminolaevulinate synthetase values represent the
means ± S.D. obtained from three experiments in which two livers were pooled in each experiment. The 8-amino-
laevulinate and porphobilinogen values are an average of two experiments. The control values of 8-
aminolaevulinate synthetase and aminolaevulinate amounts were 16.6±1.5nmol of aminolaevulinate/h per
g of liver and 1.37,ug of aminolaevulinate/g of liver respectively. No porphobilinogen could be detected in
the control livers.
Treatment
Allylisopropylacetamide (first
injection)
Allylisopropylacetamide (second
injection)
Phenobarbital (first injection)
Phenobarbital (second injection)
Haematin (second injection)
Allylisopropylacetamide +haematin
(second injection)
Phenobarbital+haematin (second
injection)
8-Aminolaevulinate
synthetase activity
(nmol of aminolaevulinate/h
per g of liver)
95.6± 11.4
150.3 ±9.6
16.9 ± 2.6
48.0± 2.8
10.5±2.0
31.2± 2.8
20.0±1.6
Liver
aminolaevulinate
content
(ytg/g of liver)
1.90
Liver
porphobilinogen
content
(,ug/g of liver)
2.2
3.40
1.10
1.20
1.15
1.31 1.1
1.16
the effects of phenobarbital, as well as allylisopropyl-
acetamide, in this regard.
Although allylisopropylacetamide induces 8-
aminolaevulinate synthetase and increases the rate of
haem synthesis, its primary effect seems to be one of
decreasing the content ofcytochrome P-450 (Table 7).
The decrease in cytochrome P-450 content owing to
allylisopropylacetamide administration has also been
reported by others and involves the breakdown of the
haem moiety (De Matteis, 1970; Meyer & Marver,
1971). Cytochrome P-450 contents reach normal or
even greater than normal values 24h after allyliso-
propylacetamide administration (De Matteis, 1971;
Satyanarayana Rao etal., 1972). The results presented
in Table 7, where cytochrome P-450 contents have
been measured 6h after each allylisopropylacetamide
injection, thus represent fresh breakdown of cyto-
chrome P-450 after each injection of the drug. The
decrease in cytochrome P-450 content is also reflected
in the decrease in the activities of aniline hydroxylase
and aminopyrine demethylase. Even a single in-
jection of phenobarbital causes an increase in cyto-
chrome P-450 content under conditions when there is
no change in 8-aminolaevulinate synthetase activity
1973
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or rate of haem synthesis. Again haematin counter-
acts the phenobarbital-mediated, but not the allyl-
isopropylacetamide-mediated, effects on drug-meta-
bolizing-enzyme activities. Another interesting fea-
ture of the comparative effects of allylisopropyl-
acetamide and phenobarbital is that both the drugs
cause an increase inNADPH-cytochrome c reductase
activity. Haematin is effective only in the case of
phenobarbital (Table 8).
Finally, Marver (1969) reported that haematin
inhibits the uptake of phenobarbital into liver
microsomes. A similar study with [2-14C]allyliso-
Table 8. Effect of haematin on allylisopropylacetamide- and phenobarbital-mediated changes in NADPH-cyto-
chrome c reductase activity
The injection schedule is the same as described in Table 1. The animals were killed 12h after the last injection.
The results are expressed as % ofthe control. The absolute value for the control is 66.8±0.8nmol ofcytochrome c
reduced/min per mg of protein and represents the means± S.D. obtained from six experiments. The other values
represent the averages of two experiments in which two livers were pooled in each experiment.
Treatment
Control
Allylisopropylacetamide
First day
Second day
Third day
Fifth day
Haematin
First day
Second day
Third day
Fifth day
Allylisopropylacetamide+haematin
First day
Second day
Third day
Fifth day
Phenobarbital
First day
Third day
Phenobarbital+haematin
First day
Third day
NADPH-cytochrome c reductase activity
(% of control)
100±4.8
111
276
315
330
97
107
140
127
125
235
310
335
120
262
105
142
Table 9. Effect of haematin on [2-'4C]allylisopropylacetamide uptake by the liver subcellular fractions
Rats were given intraperitoneal injections of haematin (2mg/1OOg). After 30min allylisopropylacetamide was
injected subcutaneously at a dose of 150mg/kg, which included 4.2,uCi of [2-14C]allylisopropylacetamide/
animal. The animals were killed 2h and 4h after allylisopropylacetamide injection and the incorporation
of radioactivity into the subcellular fractions was measured. The values given are averages of two experiments
and livers from two animals were pooled in each case.
Treatment
Allylisopropylacetamide
Allylisopropylacetamide
Allylisopropylacetamide+haematin
Allylisopropylacetamide+haematin
Radioactivity (c.p.m./g of liver) in:
Time I
(h) Homogenate Mitochondria Microsomes Cytosol
2 6328 64 458 4440
4 1196 78 120 900
2 6240 58 482 4208
4 1144 70 130 930
1973
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propylacetamide reveals that haematin has no in-
hibitory effect on the uptake of the drug by any of
the subcellular fractions examined at the time-
intervals studied. A striking decrease in radioactivity
of the liver homogenate at the 4h time-period as
compared with 2h, is an index of the rate ofclearance
of the drug from the liver (Table 9). Similar results
were obtained at two amounts of allylisopropyl-
acetamide administration, namely 150 and 400mg/
kg body wt.
Discussion
The present results clearly establish that allyliso-
propylacetamide shares several of the biochemical
effects of phenobarbital. Both the drugs elicit an
increase in liver weight, microsomal protein, RNA
and phospholipid contents as well as the rate of pro-
tein synthesis in vivo and in vitro. In addition both the
drugs depress ribonuclease activity and increase
NADPH-cytochrome c reductase activity.
Regarding the effect on haem synthesis, allyliso-
propylacetamide and phenobarbital increase the
activity of 8-aminolaevulinate synthetase and the
rate of haem synthesis (Baron & Tephly, 1969a;
Marver, 1969; Marver et al., 1966b). Detailed studies
indicate that allylisopropylacetamide causes an
almost immediate increase in 8-aminolaevulinate
synthetase activity. A striking increase in the rate of
haem synthesis was observed 8h after allylisopropyl-
acetamide administration. This time-period has been
chosen in this study to avoid the complication arising
from the initial breakdown of the haem moiety of
cytochrome P450 owing to allylisopropylacetamide
injection. At least in fed female rats phenobarbital
has a delayed effect on 8-aminolaevulinate syn-
thetase activity and the rate of total haem synthesis
as compared with that of allylisopropylacetamide.
However, phenobarbital brings about an increase in
cytochrome P450 content under conditions where
there is no change in 8-aminolaevulinate synthetase
activity or in the rate of total haem synthesis. It is
generally held that the availability of haem is rate-
limiting for the synthesis of cytochrome P450 and
the drugs increase the cytochrome P450 content by
enhancing the rate of haem synthesis through the
induction of 8-aminolaevulinate synthetase (Granick,
1966; Marver, 1969; Baron & Tephly, 1969a,b,
1970). However, the results of the present investiga-
tion indicate that at least under certain conditions
the availability of haem need not be rate-limiting for
cytochromeP450 synthesis. We have also shown that
in hexachlorobenzene feeding cytochrome P-450 con-
tent can increase without eliciting a change in 8-
aminolaevulinate synthetase activity or in the rate of
total haem synthesis (Rajamanickam et al., 1972).
Song et al. (1971) have shown that in young rats
phenobarbital causes an increase incytochromeP-450
content without affecting &-aminolaevulinate syn-
thetase. Bock et al. (1971) have shown a similar effect
in fed adult rats. Recently, De Matteis & Gibbs
(1972) have also subscribed to the view that the
primary effect of drugs affecting cytochrome P-450
content need not be at the level of haem synthesis.
The present results clearly indicate that the gross
effects of allylisopropylacetamide and phenobarbital
on 8-aminolaevulinate synthetase activity and the rate
of haem synthesis cannot explain the similar bio-
chemical effects, especially the anabolic effects exerted
by them. In other words, the sequence of action does
not appear to be one of increasing the rate of haem
synthesis and consequently the rate of microsomal
protein synthesis. In view of the report that a sub-
stantial portion of the microsomal proteins appear to
be haemoproteins (Black et al., 1971), it is important
to understand the effect of haem on the rate of
microsomal protein synthesis. The situation in liver
may be different when compared with the role of
haem in haemoglobin synthesis. The counteracting
effect of externally administered haematin on the bio-
chemical changes elicited by phenobarbital is not
because of its function as a 'co-repressor' of 8-amino-
laevulinate synthetase, but is due to its ability to
inhibit phenobarbital uptake at the microsomal level.
This contention is supported by the fact that haematin
does not counteract the biochemical changes brought
about by allylisopropylacetamide other than 8-
aminolaevulinate synthetase induction and has no
effect on the uptake of the drug by any of the sub-
cellular fractions examined. However, externally
administered haematin consistently lowered theamino
acid-incorporating ability of isolated microsomes
from allylisopropylacetamide-injected rats to a small
extent (Fig. 1).
It will be of interest to examine how phenobarbital
and allylisopropylacetamide, which seem to act
differently in the early stages, subsequently elicit
similar biochemical effects. One possibility is that
allylisopropylacetamide may elicit the formation of
mRNA for 8-aminolaevulinate synthetase during the
initial stages. Later stages involving repeated
administrations of the drug may result in increased
rRNA formation and/or stabilization. Phenobarbital
may primarily increase the formation of apo-cyto-
chrome P-450, which may subsequently elicit in-
creased formation of 8-aminolaevulinate synthetase
and haem. As suggested by Cohen & Ruddon (1970),
phenobarbital may also accelerate the processing or
transport of ribosomal precursor RNA.
This work was partly supported financially by the
Department of Atomic Energy, India.
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